The heterogeneity of post- stroke cognitive impairments is reflected
in the range of severity and variety of domain-specific and
domain-general degeneration. In addition, stroke survivors may have
visual, communication, and/or motor impairments impacting the way we
assess cognitive function. Stroke-specific cognitive screening is
required, though no single cognitive screening tool can appropriately
capture both domain-specific and general cognitive impairment at the
correct level of complexity for every single person. I will combine
validated stroke-specific cognitive screening tests in a computerised
multi-stage format which adapts to the nature and severity of the
cognitive impairments under assessment. I will co-produce the Multistage
Cognitive Screening computer-tablet app (MSC-Stroke) and reporting, with
allied health professionals and stroke survivors. I will determine 1)
the equivalency of the MSC-Stroke implemented tests with their
paper-based versions, 2) the association between functional outcomes and
MCS-Stroke performance, 3) and validate the internal structure of the
MSC-Stroke using factor analysis. 300 stroke survivors across the
stroke-pathway will be recruited. The outcome of the fellowship will be
a co-produced multi-staged cognitive screening app adjustable for most
stroke survivors across the stroke pathway. Further research will be
needed to ultimately seek medical device regulation for implementation
in clinical practice.
- Status: Active.
Funded by the commercial company Brain Stimulation AB (based in Sweden), I am working on a multi-site international trial psychometrically validating a commercial computer tablet version of the OCS. The study covers stroke wards (acute and rehab) in Sweden, Italy, and the UK. We aim to collect data for 150 stroke survivors and 100 neurologically healthy controls. We will compare the paper OCS to the DiSTRO-OCS to establish equivillance. We are currently setting projects up in the USA to validate a North American version of the OCS. - Status: Under active recruitment (Oct 2024)
There is currently no gold standard cognitive outcome measure in
stroke clinical trials. In this project, we aim to generate a total
score for the Oxford Cognitive Screening programme suit of tests. The
tests include the Oxford Cognitive Screen (OCS), the OCS-Plus, and the
Mini-OCS (see pre-prints) so that they can be used as outcome measures.
The project will include reliable change indexing, minimal detectable
change (MDC), minimal clinically important difference (MCID) indexing,
and convergent and discriminant validity evidence. We will use
distribution based methods for establishing MDC and MCID.
- Status: OCS - Manuscript in preparation (Oct 2024);
OCS-Plus - Manuscript in preparation (Oct 2024); Mini-OCS - Manuscript
pre-printed for total score.
In this project, in collaboration with statisticians and psychologist
researchers, we will compare Multivariate Normative Comparison methods
with univariate analyses techniques to establish if the methods are
sufficiently different to warrant different clinical
interpretations.
- Status: Active data analysis and manuscript
preparation (Oct 2024).
As part of a part-time role with the commercial company Peter Pease Business Psychology, I was leading the psychometric development and validation of a project generating a new personality questionnaire for employee learning and development. I was employed for nearly 18 months for this role which was remote and we produce both a long and short form of the questionnaire which was psychometrically sound. - Status: Project completed Sept 2024.
This project is in collaboration with multiple national sites across
the UK, including Dr Eugene Tang and Dr Nele Demeyere. Currently I am
collecting some initial data to support the use of the Mini-OCS. We are
preparing funding applications for this project currently. Copyright is
retained for all uses of the Mini-OCS and Mini-OCS name.
- Status: Pre-printed (above) and submitted for
publication (Oct 2024)
This project, in collaboration with Dr Suzanne Burns (the creator of
the MET-Home), will generate new
data for the MET-Home in healthy adults and stroke survivors with the
aim of generating new normative cut offs for use in clinical practice.
Currently there are no standardised norms for this task, yet we know,
with anecdotal evidence, that it is being used in clinical practice
regularly.
- Status: Pre-printed (above) and submitted for
publication (Oct 2024)
Assessment of mental capacity is a critical aspect of clinical practice. Mental capacity is a legal concept defined in statute by the Mental Capacity Act 2005 (England and Wales). Current best practice consists of a qualitative interview to elucidate the ability to (i) understand, (ii) retain and (iii) weigh up the specific information at hand, and to (iv) communicate a decision. Capacity assessments often fail to align with the legal standards and are often contentious with low agreement rates. We developed and validated a new brief neuropsychological screening tool (The Oxford Competency Assessment; COMPASS) to assess the cognitive constructs aligned to the core abilities required for mental capacity. We aim for COMPASS to help decide best practice for conducting a full mental capacity assessment in light of identified issues. That is, if a memory impairment is found, clinicians know to adapt procedures to reduce uneccessary burden on retention of information during the capacity assessment.
122 neurologically healthy participants were compared with 117 participants with neurological conditions (stroke or dementia/mild cognitive impairment) on COMPASS performance. The validation included 56 control participants and 69 neurological participants who completed additional neuropsychological tasks including the MoCA. 29 participants were re-tested. 80 participants were compared against a mental capacity assessment on setting up a hypothetical Lasting Power of Attorney.
We found great reliability of the COMPASS, convergent validity analysis revealed low but significant correlations, and divergent validation was achieved. The COMPASS total score was similar to the MoCA in identifying impairment in mental capacity assessments, but neither were adequate to differentiate impairment in core abilities (i.e., understanding, retention, or weighing up).
Further research comparing the COMPASS to capacity assessments with
differing complexity is necessary, as it may be that the decision
focussed on was too complex for an initial investigation.
- Status: In preparation (May 2024)